Skip to content

New Frontiers in Psychedelics and Mental Health

Presented by Allison Feduccia, PhD

Presenter Bio

The re-emergent field of psychedelic research is offering new opportunities to understand how these tools can be used to promote healing and well-being. My focus in this area revolves around both clinical research trials and community support. I’m the Co-Founder of Psychedelic.Support, an online platform to connect with mental health professionals and educational resources, and Co-Founder and Executive Director of Project New Day, a new nonprofit foundation aimed to help people overcome substance use disorders.

Prior to this, I worked for 5 years on the clinical trials team at MAPS Public Benefit Corporation (MAPS PBC). After earning a Ph.D. in neuropharmacology from the University of Texas at Austin by utilizing rodent models to study the effects of MDMA on behavior and neurochemical release, I held a postdoctoral research position in the Preclinical Development Group at Ernest Gallo Clinic and Research Center at the University of California San Francisco where our experiments aimed to discover novel treatment strategies for alcohol dependence by elucidating the mechanism of action of medications used to treat substance use disorders. In 2012, I received a Postdoctoral Research Training Award from the National Institutes of Health that enabled me to work on clinical trials at NIAAA in Bethesda, MD investigating novel therapeutics for alcoholism.

What are psychedelics? Why are they under investigation for treating mental health conditions? How are psychedelic-assisted therapies administered and what does the research tell us?

Join for a presentation to discover how psychedelic-assisted therapies are delivered in clinical trials to treat mental health conditions. You will learn the key facts on how MDMA, psilocybin, and ketamine work in the body and how these substances are combined with therapeutic approaches. Become knowledgeable on clinical protocols, safety and efficacy results, study participant accounts, and potential risks in both medical and non-medical settings. You will explore different therapeutic approaches for ketamine and those under investigation for MDMA and psilocybin treatments.

Course Objectives

At the conclusion of this course, participants will be able to:

  • Explain the history of psychedelics from their discovery to modern-day psychiatric uses.
  • Describe how psychedelics (MDMA, psilocybin, and ketamine) work in the brain and body to induce psychological and physiological effects.
  • Discuss the safety profile of common psychedelics in both medical and non-medical contexts.
  • List contraindicated medical conditions and medications for psychedelic use.
  • Describe clinical uses of psychedelics including protocols, routes of administration, dosing, and therapeutic frameworks.
  • Explain the state of clinical research on MDMA, psilocybin, ketamine, and other psychedelic compounds for psychiatric indications.
  • Summarize how clinicians deliver psychedelic-assisted psychotherapy and outcomes in clinical trials.

Instructional Level


Licensed mental health professionals employed through Kaiser Permanente and psychological assistants performing under supervision of a licensed psychologist.

This CE program is free to Kaiser Permanente employees.

Instructional Methodology

On-line Presentation

Continuing Education Information

Kaiser Permanente Northern California Mental Health Training Program is approved by the California Psychological Association to provide continuing professional education for psychologists. The Kaiser Permanente Northern California Mental Health Training Program maintains responsibility for this program and its content.

Refund and Attendance Policy

All programs offered on KP Learn for CE credit through the KP Northern California Mental Health Training website are free of charge to Kaiser Permanente Staff and trainees. Once a course is selected in the KP NCAL MH Training Website, the registration process begins, and it will appear in the individuals KP Learn profile for completion within 90 days.

IMPORTANT NOTICE: Those who attend the program in full and complete the appropriate evaluation form will receive CE credits. Please note that credit will only be granted to those who attend the entire program. An attestation of attendance will be given once the individual has completed viewing the program, which will then initiate the final steps of completing the evaluation forms to receive a certificate of completion.

Back To Top